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ABSTRACT  
 
The present work estimates occupational exposure of healthy and non-smoking Portuguese 
firefighters to polycyclic aromatic hydrocarbons (PAHs) through the analysis of four urinary 
metabolites (OH-PAHs): 1-hydroxyacenaphthene, 1-hydroxynaphthalene, 1-hydroxypyrene 
(PAH biomarker of exposure), and 3-hydroxybenzo[a]pyrene (PAH biomarker of 
carcinogenicity). Firemen from several Portuguese corporations were asked to provide urine 
samples during the winter period (without exposition to fires; pre-fire season) and during the 
summer season of 2014 after fires fighting. The selected OH-PAHs were extracted from urine 
samples by solid-phase extraction and analyzed by high-performance liquid chromatography 
with fluorescence detection. Normalization of the urinary PAH-metabolite levels was achieved 
by analyzing the creatinine concentrations. 1-hydroxynaphthalene and 1-hydroxyacenaphthene 
were the most abundant metabolites, followed by 1-hydroxypyrene. The metabolite 3-
hydroxybenzo[a]pyrene was not detected. Total OH-PAHs ranged from 0.02 to 4.01 μmol/mol 
creatinine and between 0.55 to 8.39 μmol/mol creatinine, respectively, for non exposed and 
exposed firefighters. In general, the detected concentrations of urinary PAH metabolites were 
higher during the fire season than in the winter season.  
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1.  Introduction 
Every year, southern European countries such as Portugal, Spain, Italy, and Greece are 
exposed to severe forest fires which have been reducing forested areas at a remarkable rate. 
Smoke pollution due to events of forest fires represents potential health risks for the directly 
affected population but also for personnel involved in fire suppressions. Mortality and morbidity 
studies of firefighters, although they have produced inconsistent evidence, have raised the 
possibility of increased risks of cardiovascular and respiratory diseases, cancer of nervous, 
haematopoietic/lymphatic, respiratory and gastrointestinal systems, probably due to exposure to 
smoke components [1-2]. Smoke from fires is a complex mixture of gas–, liquid–, and solid–
phase chemicals, many of them being known or potential/possible carcinogens to humans [3]. 
In that regard, polycyclic aromatic hydrocarbons (PAHs) are among the most important air 
pollutants.  U.S. EPA considers 16 PAHs as priority pollutants, some being referred to as 
persistent organic pollutants and endocrine disrupting chemicals [4]; benzo[a]pyrene is the only 
PAHs classified as carcinogenic to humans [5]. PAHs are a class of organic chemical 
compounds that are formed during pyrolysis or incomplete combustion of organic matter. 
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Humans are exposed to PAHs from air, water and food [6-8]. However, PAHs monitoring is 
complicated by mixed aerosol/vapour composition of airborne compounds and by absorption of 
these chemicals from inhalation and dermal contact. For these reasons, investigators have 
turned to biological monitoring to assess exposures to PAHs. The use of urinary biomarkers of 
exposure (OH-PAHs) constitutes an effective tool to assess total exposure to PAHs. About 90% 
of total urinary excretion of pyrene is in the form of 1-hydroxypyrene (1OHPy) [9], making this 
metabolite the most widely used biological indicator of internal dose of exposure to PAH (PAH 
biomarker) [10]. 3-hydroxybenzo[a]pyrene (3OHB[a]P) is the most common benzo[a]pyrene 
metabolite and is more representative of PAHs carcinogenic risk than 1OHPy, thus it has been 
proposed as PAH carcinogenic biomarker[11]. Naphthalene (possible human carcinogen, [12]) 
is the most volatile PAH and is eliminated from the human body mainly as 1- or 2-naphthol 
conjugates [13]. The present study aims to evaluate occupational exposure of Portuguese 
firefighters to PAHs focusing on the most relevant urinary metabolites: 1-hydroxyacenaphthene, 
1-hydroxynaphthalene, 1OHPy and 3OHB[a]P.  
 
2. Experimental 
2.1. Sample collection 
The urinary samples were collected from twenty healthy and non-smoking firemen in two 
different Portuguese corporations located in the district of Bragança (North of Portugal). The 
study subjects were asked to provide urine samples during the winter period (without exposure 
to fires; pre-fire season) and in the summer season of 2014 after firefighting activities. Urine 
samples were collected within 8 hours after fire exposure. In addition, the firemen also filled a 
structured questionnaire in order to characterize the fire incident and to identify other potential 
exposure routes to PAHs.  
 
2.2. Extraction of oh-pahs 
Briefly, an aliquot of 10 mL urine was adjusted to pH 5.0 with 0.5 mol/L HCl and buffered with 
20 mL of 0.1 M acetate [14]. After the addition of 20 μL of 1.0 g/L tert-butylhydroquinone and 80 
μL of β-D-glucuronidase/arylsulfatase (EC 3.2.1.31/EC3.1.6.1; 5.5/2.6 U mL-1) from Helix 
pomatia (Roche Diagnostics, Indianapolis, USA) urines were purged under nitrogen flow during 
30 min and incubated at 37 ºC for 120 minutes, under constant stirring and in the absent of light. 
Sep-Pak® Light Plus C18 cartridges (Waters, Portugal) were activated with 5 mL methanol and 
10 mL of water. The hydrolyzed urine samples were loaded into the activated C18 cartridges 
and sequentially washed with 10 mL of water and 10 mL of 20% methanol in water. The 
cartridges were completely dried under vigorous air flow and manually eluted with 20 mL of 
methanol/ethyl acetate (10/90). Samples were then evaporated till dryness with a rotary 
evaporator at room temperature, redissolved in 500 μL of methanol and filtered through a 0.22 
µm PTFE syringe filter before chromatographic analysis. 
The urinary creatinine levels were quantified according to the Jaffe colorimetric method [15] and 
were used to normalize the metabolite concentrations.  
 
2.3. Chromatographic analysis 
All extracts were analyzed using a Shimadzu LC system (Shimadzu Corporation, Kyoto, Japan) 
equipped with an LC-20AD pump (high-pressure gradient solvent delivery module equipped 
with two dual-plunger tandem-flow pumps), DGU-20AS degasser and a fluorescence RF-10AXL 
(FDL) detector. Separation of the compounds was performed in a C18 column (CC 150/4 
Nucleosil 100-5C18 PAH, 150- 4.0 mm; 5 mm particle size; Macherey-Nagel, Duren, Germany) 
using a mobile phase composed by a mixture of methanol- water. The injected volume was 50.0 
μL. Each compound was detected at its optimum excitation/emission wavelength pair: 232/337 
nm for 1OHNapt and 1OHAce, 242/388 nm for 1OHPy, and 308/432 nm for 3OHB[a]P. External 
calibrations with matrix-matched OH-PAHs mixed standards, using at least 5 calibration points, 
were performed. Calibrations curves were linearly fitted with correlation coefficients always 
higher than 0.9980 for all compounds. Detection limits in urine samples ranged between 0.0015 
μg/L for 1OHPy to 0.31 μg/L for 1OHNapt+1OHAce. Each analysis was performed in triplicate. 
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3. Results and discussion  
Exposure biomarker levels represent the absorbed dose of a chemical, integrated across all 
microenvironments and routes of exposure. Thus biomarker levels account for factors that 
modify the relationship between environmental concentrations and dose, including use of 
personal protective equipment, interindividual differences in absorption, ventilation, exertion, 
and personal behaviors that modify exposure such as reducing physical activity when smoke 
levels increase. The most relevant PAH metabolites: 1-hydroxyacenaphthene, 1-
hydroxynaphthalene, 1OHPy and 3OHB[a]P were determined in urine, since they have been 
proposed as biomarkers for smoke exposures. In the majority of PAHs exposure studies, only 
1OHPy is used. Combination of several metabolites is a more robust exposure approach than 
using a single one. Mean total OH-PAHs was 1.74 μmol/mol creatinine (0.02 – 4.01 μmol/mol 
creatinine) for firefighters during the winter season and 2.54 μmol/mol creatinine (0.55 – 8.39 
μmol/mol creatinine) for firefighters during the fire season. 1OHNapt+1OHAce concentrations 
were 1.94 μmol/mol creatinine (0.50 to 3.99 μmol/mol creatinine) and 2.49 μmol/mol creatinine 
(0.52 to 8.27 μmol/mol creatinine), respectively, for non-exposed and exposed firefighters 
(Figure 1). 1OHNapt and 1OHAce were detected at much higher concentrations than 1OHPy (~ 
40 to 45 times), contributing with more than 85% for the total urinary OH-PAH levels. Indeed 
naphthalene and acenaphthene are composed by two fused aromatic rings, and thus they are 
mainly present in the gas phase of the air, while PAHs with a higher number of aromatic rings 
tend to be adsorbed to the particulate phase. Regarding the metabolite of the biomarker of 
exposure to PAHs, 1OHPy, its levels ranged between 0.04 μmol/mol creatinine (0.02 – 0.09 
μmol/mol creatinine) to 0.06 μmol/mol creatinine (0.02 – 0.12 μmol/mol creatinine), respectively, 
during the winter and fire fighting seasons. 3OHB[a]P, the hydroxyl PAH biomarker of 
carcinogenicity, was not detected. Regarding the possible health impact, this result should be 
observed with caution since B[a]P metabolites are predominantly excreted through the faeces 
due to the high number of aromatic rings [16].  
 
Figure 1: 1OHNapt+1OHAce and 1OHPy concentrations in the urine of non-exposed and exposed 
Portuguese firefighters. 
Concerning the occupational exposure the use of protective equipment, particularly masks, is 
an important issue for the exposure assessment. Analyzing the data from questionnaires, it may 
be concluded that all firefighters used a protection suit during fire fighting activities, however 
very few subjects utilized the respiratory protective equipment. Portuguese professional and 
volunteer firefighters used only partially or not at all respiratory protection, presumably due to 
the impression of low smoke intensity (e.g. during the “mop-up” phase of fires), added to the 
physiological demands and heat stress placed upon users, and difficulty to communicate while 
wearing a mask. The firemen involved in this study reported an exposure period of 3, 4 and 5 
hours in the fire incident. Taking into account the number of hours exposed to fires and the 
concentrations of OH-PAHs detected, it is possible to observe that higher OH-PAH levels 
seemed to occur when the duration of exposure to fires increased. Still, this preliminary findings 
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need to be validated by more comprehensive study. No standard reference or occupational 
guidelines are available for levels of urinary OH-PAHs. Recently, Jongeneelen [17] proposed a 
guidance value of 1.0 μmol/mol creatinine for 1OHPy in urine of PAH-exposed workers based 
on a review of the cross-sectional studies available in the literature. The 1OHPy urinary levels of 
firefighters were below that threshold while total OH-PAHs exceeded that benchmark even for 
non-exposed firefighters.   
 
4. Conclusions 
The present work contributes to fill a gap regarding the assessment of firefighters occupational 
exposure through determination of four most common PAH metabolites in urine samples 
collected during different pre and post fires periods. Overall, the detected concentrations of 
urinary metabolite were higher in exposed firefighters than in the non-exposed subjects. 
Considering the relevance of this topic, the present study is currently being extended to a higher 
number of Portuguese corporations in order to assess exposure in more representative 
firefighter population. The (chemical and physical) complexity and toxicity of wildfires smoke, as 
well as physical and emotional stress encountered during firefighting, indicate the need for 
further studies of firefighters occupational exposure in order to fully comprehend the respective 
impacts on health. This is especially relevant considering the expected increasing trend of forest 
fires due to climacteric alterations.  
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